VIS
VRTX icon

Vega Investment Solutions’s Vertex Pharmaceuticals VRTX Stock Holding History

Vega Investment Solutions’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$77K Buy
155
+82
+112% +$36.3K 0.01% 115
2026
Q1 		$32.6K Hold
73
– – 0.01% 123
2025
Q4 		$33.1K Buy
+73
New +$31.5K 0.01% 135
2025
Q2 		$32.5K Sell
73
-298
-80% -$137K 0.01% 140
2025
Q1 		$186K Buy
+371
New +$173K 0.04% 91

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Vega Investment Solutions's VRTX Position: Q2 2026 in Review

Vega Investment Solutions increased its Vertex Pharmaceuticals (VRTX) stake by 112% in Q2 2026, buying an estimated $36.3K and bringing the position to 155 shares worth $77K. The position accounts for 0.01% of the portfolio, ranked #115.

Vega Investment Solutions first reported a position in VRTX in Q1 2025 and has held it in 5 quarters since. The position peaked at $186K in Q1 2025. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Vega Investment Solutions held 155 shares of Vertex Pharmaceuticals worth $77K as of Q2 2026.
  • Vega Investment Solutions bought 82 Vertex Pharmaceuticals shares in Q2 2026, an estimated $36.3K.
  • Vertex Pharmaceuticals made up 0.01% of Vega Investment Solutions's portfolio in Q2 2026, its #115 holding.
  • Vega Investment Solutions first reported a position in Vertex Pharmaceuticals in Q1 2025 and has held it in 5 quarters since.
  • Vega Investment Solutions's Vertex Pharmaceuticals position peaked at $186K in Q1 2025.
  • 1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Vega Investment Solutions's 13F filing for Q2 2026, filed 13 Aug 2026.